RT Book, Section
A1 Roberts, John R.
A2 Sugarbaker, David J.
A2 Bueno, Raphael
A2 Colson, Yolonda L.
A2 Jaklitsch, Michael T.
A2 Krasna, Mark J.
A2 Mentzer, Steven J.
A2 Williams, Marcia
A2 Adams, Ann
SR Print(0)
ID 1105842265
T1 Pneumonectomy
T2 Adult Chest Surgery, 2e
YR 2015
FD 2015
PB McGraw-Hill Education
PP New York, NY
SN 978-0-07-178189-3
LK accesssurgery.mhmedical.com/content.aspx?aid=1105842265
RD 2024/04/19
AB As  long  as  surgery  remains  the  best  curative  treatment  for  lung  cancer,  patients  will  continue  to  require  pneumonectomy  to  treat  lung  cancer  and  for  other  occasional  problems.1  Arguably,  no  other  surgery  carries  as  high  a  risk  for  perioperative  mortality  as  pneumonectomy.  Operative  mortality  from  pneumonectomy  has  been  reported  to  be  between  5%  and  20%.2–8  In  a  meta-analysis  of  27  studies,  90-day  mortality  for  right  pneumonectomy  was  20%  and  left  pneumonectomy  was  9%,  for  an  overall  mortality  of  11%.9  For  this  reason,  appropriate  selection,  operative  technique,  and  postoperative  management  of  patients  who  potentially  may  undergo  pneumonectomy  is  crucial.  We  say  potentially  because  patients  scheduled  for  pneumonectomy  ultimately  may  undergo  a  sleeve  resection  or  exploration  without  resection  depending  on  the  findings  at  surgery.